Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
54 Cards in this Set
- Front
- Back
What mediates the activation of complement proteins of the immune system?
|
Microbial surfaces or by antibody-antigen complexes.
|
|
What are the three complement activation pathways?
|
1. Classical
2. MB-Lectin 3. Alternative |
|
In classical activation pathway, what causes C1s to become an activated enzyme?
|
Binding of C1q, C1r, and C1s to antigen and IgG (or IgM)
|
|
In classical activation pathway, what does C1s active enzyme do?
|
Cleaves C2 in to C2a and C2b.
Cleaves C4 in to C4a and C4b. |
|
In classical activation pathway, what cleaves C3?
|
C4b2a enzyme
|
|
What is the C3 convertase in Classical activation pathway?
|
C4b2a
|
|
In classical pathway, what happens to C3 convertase after it cleaves C3?
|
Binds with C3b to form C4b2a3b.
|
|
In classical pathway, what does C4b2a3b do?
|
Cleaves C5 into C5a and C5b
|
|
What is similar about all three pathways?
|
C5b will recruit C6, C7, C8, and C9 into a self-assembled complex. C9 of this complex will "drill" a transmembrane pore inducing cell lysis.
|
|
In classical pathway, what is the C5 convertase?
|
C4b2a3b
|
|
In classical pathway, what is required?
|
Antibody (acquired immunity)
|
|
In MB-lectin pathway, what is initially required?
|
A mannan-binding lectin must bind to a mannose on microbial surface.
|
|
In MB-lectin pathway, a complex of mannose and MB-lectin leads to what?
|
Binding of MASP I and MASP II.
|
|
In MB-lectin pathway, what do the MASP's do?
|
Cleave C2 (into C2a and C2b) and C4 (into C4a and C4b)
|
|
In MB-lectin pathway, what happens after MASP cleavage?
|
Formation of C4b2a
|
|
In MB-lectin pathway, what is the C3 convertase?
|
C4b2a
|
|
What does the C3 convertase do and what is the final product in the MB-lectin pathway?
|
C3 convertase cleaves C3 into C3a and C3b. This forms C4b2a3b.
|
|
In MB-lectin pathway, what is the C5 convertase?
|
C4b2a3b
|
|
In the alternative pathway, what must occur initially?
|
Slow spontaneous hydrolysis of the thioester in C3.
|
|
In the alternative pathway, what happens after C3 is hydrolyzed?
|
Factor B comes in and gets attached.
|
|
In the alternative pathway, what does Factor D do and what is the resultant product?
|
Cleaves Factor B on the C3B complex to Ba and Bb. This results in C3Bb complex.
|
|
In the alternative pathway, what is the C3 convertase?
|
C3bBb
|
|
In the alternative pathway, what happens to C3Bb and what is the result product?
|
Cleaves the C3 on itself into C3a and C3b leading to the formation of C3bBb
|
|
In the alternative pathway, what is the event immediately following formation of C3bBb?
|
C3bBb forms many molecules of C3b which attach to the microbe.
|
|
In the alternative pathway, what does C3bBb bind to?
|
An additional C3b to form C3bBb3b.
|
|
In the alternative pathway, what does C3bBb3b bind to?
|
Factor P
|
|
In the alternative pathway, what is the C5 convertase?
|
C3bBb3bP
|
|
Describe the properties of C5a
|
Vasoactive and chemotactic properties.
|
|
Describe the properties of C3a.
|
Increases vasodilation and vascular permeability contributing to inflammation
|
|
In the MB-lectin pathway, what is the stabilizing event?
|
The binding to microbial surfaces.
|
|
In the alternative pathway, what is the stabilizing event?
|
Factor P (properdin) binding to C3bBb3b.
|
|
How is systemic activation prevented in the complement pathways?
|
As activated components move farther ways from sites of activation, they are more likely to be susceptible to inhibitors.
|
|
What can be said about disorders of complement proteins?
|
Very rare.
|
|
What is the difference between primary vs secondary immune deficiency diseases?
|
Primary's are congenital and secondary's are disorders associated with induced molecules or cells such as complements.
|
|
List three classes of lipid mediators derived from arachidonic acid.
|
1. Prostaglandins
2. Leukotrienes 3. Thromboxanes |
|
NSAID's inhibit what precursor of what lipid mediator(s)?
|
Inhibits cyclooxygenase thus inhibiting prostaglandins and thromboxanes
|
|
Effects of prostaglandins. x 3
|
1. Increase vasodilation
2. Increase vascular permeability. 3. Increase pain perception |
|
Effects of thromboxanes x 2
|
1. Increases platelet aggregation
2. Increases vasoconstriction |
|
Effects of Prostacyclins x 2
|
1. Inhibits platelet aggregation
2. Increases vasodilation |
|
The peptide, Bradykinin, causes what in what condition?
|
Mild inflammation in the absence of infection.
|
|
What is the peptide, Bradykinin, activated by?
|
Blood clotting.
|
|
Bradykinin acts through what receptors?
|
B1 and B2 receptors.
|
|
What are the vascular effects of Bradykinin?
|
1. Increase vasodilation
2. Increase vascular permeability. |
|
What are the effects of serotonin and histamine? x 2
|
1. Increase vasodilation
2. Increase vascular permeability |
|
Where are serotonin and histamine derived from? x 4
|
Basophils
Eosinophils Mast cells Platelets |
|
What does nitric oxide increase in responsive cells?
|
cyclic GMP
|
|
Nitric Oxide is produced by three enzymes. Name two.
|
1. iNOS (NOS1)
2. eNOS (NOS3) |
|
Where is iNOS made and what does it do?
|
Made in macrophage and produces anti-microbial effects.
|
|
What is eNOS and what does it do?
|
Endothelial NO synthase. Increases vasodilation and increases vascular permeability.
|
|
Are cytokines local or systemic?
|
Local
|
|
What do cytokines do in general?
|
Act on receptors to alter cell function
|
|
Constituitively expressed chemokine receptors generally involved in what?
|
Trafficking
|
|
Inducible chemokine receptors involved in what?
|
Inflammation
|
|
What are the co-receptors of HIV-1? x 2
|
CCR5 and CXCR4
|